等待開盤 01-13 09:30:00 美东时间
+0.110
+0.51%
Midland States Bancorp, Inc. (NASDAQ: MSBI) announced it will release its fourth quarter 2025 financial results after market close on January 22, 2026, along with an investor presentation available on its investor relations website. The company, based in Effingham, Illinois, had total assets of approximately $6.91 billion as of September 30, 2025, and offers a range of financial services including commercial and consumer banking, wealth managemen...
01-02 21:30
今日重点评级关注:Ascendiant Capital:维持GRI Bio"买入"评级,目标价从35美元升至36美元;Ascendiant Capital:维持Atossa Therapeutics"买入"评级,目标价从7.75美元升至8美元
2025-12-09 10:32
今日重点评级关注:B. Riley证券:维持Seabridge Gold"买入"评级,目标价从50美元升至65美元;HC Wainwright & Co.:维持TRX Gold"买入"评级,目标价从1.2美元升至1.4美元
2025-12-03 09:58
Midland States Bancorp, Inc. (NASDAQ:MSBI) today announced that its wholly owned subsidiary, Midland States Bank ("the Company"), has sold substantially all of its equipment finance portfolio to an affiliate of North
2025-12-01 22:06
An announcement from Midland States Bancrop ( ($MSBI) ) is now available. On No...
2025-11-07 05:58
今日重点评级关注:瑞银:维持Syndax Pharmaceuticals"买入"评级,目标价从35美元升至38美元;HC Wainwright & Co.:维持Benitec Biopharma"买入"评级,目标价从28美元升至35美元
2025-11-05 10:35
今日重点评级关注:花旗:维持Caribou Biosciences"买入"评级,目标价从5美元升至8美元;HC Wainwright & Co.:上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入",目标价30美元
2025-11-04 10:31
Midland States Bancorp, Inc. (NASDAQ:MSBI) announced today that its Board of Directors has approved a new stock repurchase program that authorizes the Company to repurchase up to $25 million of its common stock. The new
2025-11-04 05:47
Keefe, Bruyette & Woods analyst Damon Delmonte maintains Midland States Bancorp (NASDAQ:MSBI) with a Market Perform and lowers the price target from $20 to $17.
2025-11-04 00:55
Midland States Bancrop ( ($MSBI) ) has issued an announcement. Midland States B...
2025-10-31 04:49